tiprankstipranks
Trending News
More News >
Invex Therapeutics Ltd. (AU:IXC)
ASX:IXC
Australian Market
Advertisement

Invex Therapeutics Ltd. (IXC) Revenue

Compare
2 Followers

Invex Therapeutics Ltd. Revenue

Invex Therapeutics Ltd. had a revenue of 229.08K in the quarter ending Jun 30, 2025, with Infinity%. This bring the company's revenue in the last twelve months to 229.08K, Increased -81.10%. In the fiscal year ending Dec 31, 2025, Invex Therapeutics Ltd. had annual revenue of 229.08K with -81.10% growth.
Revenue (ttm)
229.08K
Revenue Growth
P/S Ratio
37.73
Revenue/Employee
Employees
Market Cap
AU$8.64M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
229.08K-982.92K+18.90%
Dec 31, 2024
1.21M752.91K+264.00%
Dec 31, 2023
459.08K276.83K+251.90%
Dec 31, 2022
182.25K-18,225,100.00%
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis